Literature DB >> 3517208

The role of extracellular matrix proteins in the control of phagocytosis.

E J Brown.   

Abstract

The phagocytic function of human-peripheral-blood-derived mononuclear and polymorphonuclear leukocytes can be regulated by external stimuli. In particular, the extracellular matrix (ECM) proteins fibronectin and laminin and serum amyloid P component can increase the phagocytic activity of these cells. Phagocytosis enhancement by the ECM requires two distinct signals to the ingesting cell. First, a ligand for interaction of the target particle with phagocytic cells is required. Generally this occurs because of opsonins such as antibody or complement on the phagocytic target and is independent of the ECM proteins. The phagocytosis-enhancing effect of the connective tissue proteins also requires direct interaction of these proteins with phagocytic cells and occurs through cell surface receptors for these molecules. In the case of neutrophils, sensitivity to the phagocytosis-enhancing effects of connective tissue proteins requires prior stimulation with the chemotactic peptides C5a or f-met-leu-phe. The present state or knowledge of the mechanism of phagocytosis enhancement by ECM proteins and the implications of the phenomenon for host defense are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517208     DOI: 10.1002/jlb.39.5.579

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

3.  Wound angiogenesis as a function of tissue oxygen tension: a mathematical model.

Authors:  Richard C Schugart; Avner Friedman; Rui Zhao; Chandan K Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

Review 4.  Fragments of extracellular matrix as mediators of inflammation.

Authors:  Tracy L Adair-Kirk; Robert M Senior
Journal:  Int J Biochem Cell Biol       Date:  2007-12-24       Impact factor: 5.085

5.  Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation.

Authors:  J L Carpentier; D P Lew; J P Paccaud; R Gil; B Iacopetta; M Kazatchkine; O Stendahl; T Pozzan
Journal:  Cell Regul       Date:  1991-01

6.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

7.  Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; J Verhoef
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 8.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

Review 9.  Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis).

Authors:  I Ginsburg
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

10.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.